September 2026 Japanese M&A Market Trends and GIP Advisory Track Record."In this webinar, we will explain the trends and notable deals in the Japanese M&A market for the July-September 2026 period, as ...

Viking Therapeutics Inc VKTX shares are popping Thursday. The obesity drug developer reported third-quarter results that ...

Retatrutide is widely expected to fuel Lilly's next wave of growth following the success of its Zepbound and Mounjaro.

Topline Phase 3 results show Eli Lilly’s retatrutide beat Novo’s Ozempic on measures of blood sugar and weight loss in adults ...

In the first head-to-head trial of Ozempic versus Eli Lilly's new "King Kong" drug retatrutide, the next-generation drug led ...

Eli Lilly’s next generation weight loss drug, known as retatrutide, was shown to provide more than double the weight loss of ...

Eating rich holiday foods while taking a drug like Ozempic, Wegovy, Mounjaro, or Zepbound can cause digestive issues. Doctors ...

Olive oil has long been praised for its health benefits, often considered "green gold" by many of its strongest supporters.

I think there are quite a few people who say, "I feel sluggish after eating a meal."🍚Some say they feel sluggish after ...

Eli Lilly’s latest weight loss drug candidate, retatrutide, is already being talked about as a potential game changer in ...

Shares of Viking Therapeutics (VKTX) fell nearly 3% overnight late Wednesday after posting a wider-than-expected quarterly ...

Fluence Energy is rated buy with a 12-month $9 price target, contingent on resolving Houston plant bottlenecks. Read why FLNC ...